AI-generated image
The relationship in one paragraph.
The Biotechnology Ignition Grant (BIG) and the Sustainable Entrepreneurship and Enterprise Development (SEED) Fund are complementary funding mechanisms administered by the Biotechnology Industry Research Assistance Council (BIRAC) to support Indian biotechnology startups [1]. BIRAC BIG functions as an early-stage, non-dilutive grant-in-aid, providing up to ₹50 Lakhs over 18 months to enable innovators, researchers, and early startups to validate their ideas and transition from ideation to the Proof of Concept (PoC) stage [1, 2]. The BIRAC SEED Fund operates as a follow-on investment mechanism, providing up to ₹30 Lakhs in equity or equity-linked capital to bridge the gap between PoC and commercial scale [1]. Bio-innovation founders can stack these programs by utilizing the non-dilutive BIG grant to clear prototyping and early lab-testing hurdles, and then leveraging their validated PoC to apply for equity-linked SEED capital through BIRAC's BioNEST incubator network to fund advanced testing, clinical trials, and market-entry initiatives [1, 2].
Side-by-side facts.
| Feature | Biotechnology Ignition Grant (BIG) [1] | BIRAC SEED Fund [1] |
|---|---|---|
| Development Stage | Ideation to Proof of Concept (PoC) validation [1] | Post-PoC, ready for trial-scaling and market entry [1] |
| Funding Quantum | Non-dilutive grant-in-aid up to ₹50 Lakhs [1] | Equity or equity-linked debt up to ₹30 Lakhs [1] |
| Funding Type | Grant-in-aid (no equity dilution, non-refundable) [1] | Dilutive investment (equity, convertible debentures) [1] |
| Project Duration | Maximum 18 months [1] | Milestone-based (flexible scaling timeline) [1] |
| Incubation Rules | Mandatory incubation at a BIRAC-partner BioNEST incubator [1] | Must be incubated or hosted at a SEED-operating BioNEST site [1] |
| Eligibility Gates | Individuals, researchers, or startups under 5 years old [1, 2] | Startups under 5 years with 51%+ resident Indian ownership [1] |
Figure 2: BIRAC BIG & SEED early prototyping and equity-linked funding integration milestones, eligibility comparison, and BioNEST workflows. [AI Generated]
The recommended order, and why.
For early-stage biotechnology startups, the recommended sequencing is BIRAC BIG non-dilutive grant first, followed by BIRAC SEED equity funding.
- Secure BioNEST Incubation: Apply to and secure incubation space at a BIRAC-partner BioNEST incubator [1]. Having access to specialized lab facilities, biosafety cabinets, and testing infrastructure is a prerequisite for biological experiments and licensing [1, 2].
- Apply for BIRAC BIG Grant: Submit your prototyping project report during the national BIG call windows (typically twice a year) to secure up to ₹50 Lakhs in non-dilutive funding [1, 2].
- Validate Proof of Concept (PoC): Use the grant over 18 months to execute lab work, complete gene-sequencing, or build early medical diagnostic prototypes [1]. Secure your official PoC validation certificate from your BioNEST host incubator [1, 2].
- Transition to SEED Funding: Once the PoC is verified, apply for the BIRAC SEED Fund (up to ₹30 Lakhs) at a partner BioNEST incubator [1]. Use this equity capital to transition from the lab to commercial testing, run safety/efficacy trials, and prepare dossiers for regulatory licensing [1, 2].
Common mistakes.
- Applying for SEED funding without a validated PoC: The BIRAC SEED Fund is designed for market transition, not basic research [1]. Startups that apply for SEED funding with only an idea or paper blueprint are rejected, as the investment committee requires physical trial data or prototype results [1].
- Failing to maintain 51% Indian resident ownership: The SEED Fund guidelines strictly mandate that at least 51% of the company's equity must be held by resident Indian citizens [1]. Raising early offshore VC funding that dilutes Indian founders below this threshold will disqualify the company from receiving SEED support [1].
- Double-dipping or mixing grant accounts: Startups must open a dedicated, interest-bearing bank account for the BIG grant [1]. Commingling these funds with personal accounts or using BIG capital for commercial manufacturing will trigger immediate audits and potential blacklisting by BIRAC [1].
- Missing the support contact guardrail: When facing technical difficulties with online submissions, do not publish internal passwords or email addresses. Contact the BIRAC support desk via birac.big [at] nic [dot] in or the BioNEST coordinator to keep credentials secure.
Next step.
Map your biotechnology startup journey:
- Run the Eligibility Wizard to verify if your registration date and entity type meet the BIRAC startup criteria.
- Explore the Make in India scheme page to discover matching state-level biotech parks and common manufacturing facilities.